Supernus Pharma (SUPN) Reports Q4 Revenue of $155M
Go back to Supernus Pharma (SUPN) Reports Q4 Revenue of $155M| SUPERNUS PHARM (NASDAQ: SUPN) | Delayed: 47.78 +0.63 (1.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $47.15 | 52 Week High | $26.84 | |||
| Open | $46.70 | 52 Week Low | $9.51 | |||
| Day High | $47.86 | P/E | N/A | |||
| Day Low | $46.57 | EPS | $-2.62 | |||
| Volume | 105,660 | |||||

